SCHEMBL6167853

SCHEMBL6167853

CCc1noc(-c2ccccc2)c1-c1ccc(SC)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 5/20 0.43
PTGS1 P23219 3/20 0.42
PTPN1 P18031 1/20 0.42
IP6K1 Q92551 1/20 0.38
DHFR P00374 1/20 0.38
HEXA P06865 1/20 0.38
HEXB P07686 1/20 0.38
MLYCD O95822 1/20 0.36
MEN1 O00255 1/20 0.36
NPC1 O15118 1/20 0.36
GAA P10253 1/20 0.36
RAB9A P51151 1/20 0.36
KMT2A Q03164 1/20 0.36
ALDH1A3 P47895 1/20 0.36
ALDH1A1 P00352 1/20 0.36
HPGD P15428 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
BRD4 O60885 2/20 0.36
GABRA5 P31644 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6169007 0.89 PTGS1 (0.50) PTGS2PTGS1PTPN1IP6K1DHFR
SCHEMBL6169852 0.84 MAPK10 (0.46) PTGS2PTGS1PTPN1DHFRHEXA
SCHEMBL8475581 0.82 BRD4 (0.53) PTGS2PTGS1PTPN1MEN1NPC1
SCHEMBL6170940 0.82 BRD4 (0.53) PTGS2PTGS1PTPN1MEN1NPC1
Sulfamide SCHEMBL4639248 0.81 PTPN1 (0.46) PTGS2PTGS1PTPN1IP6K1DHFR
SCHEMBL6168431 0.80 PTGS2 (0.54) PTGS2
SCHEMBL213407 0.78 PTGS2 (0.57) PTGS2PTGS1
SCHEMBL6168613 0.78 PTGS2 (0.57) PTGS2PTGS1
SCHEMBL10920153 0.71 PTGS1 (0.49) PTGS2PTGS1DHFRHEXAHEXB
SCHEMBL12088082 0.71 DHFR (0.44) PTGS2PTGS1PTPN1IP6K1DHFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1214790-C Medicinal composition for treating inflammation SEARLE & CO (US) 2005-08-17 CN disclosed
EP-1528059-A2 Substituted isoxazoles for the treatment of inflammation G.D. Searle LLC (US) 2005-05-04 EP disclosed
CN-1442139-A Medicinal composition for treating inflammation SEARLE & CO (US) 2003-09-17 CN disclosed
EP-0809636-B1 SUBSTITUTED ISOXAZOLES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2002-09-04 EP disclosed
EP-1223167-A2 Substituted isoxazoles for the treatment of inflammation G.D. Searle & Co. (US) 2002-07-17 EP disclosed
US-5859257-A ANTIINFLAMMATORY, ANTIARTHRITIC AGENTS G. D. SEARLE & CO. (US) 1999-01-12 US disclosed